What project 635323 buys
This Project develops, demonstrates, and transitions Human Effectiveness technologies required for Department of the Air Force (DAF) warfighters to win future wars through enabling, augmenting and protecting warfighter performance. This project demonstrates technologies to predict, evaluate, and mitigate the effects of novel weapon systems on personnel and mission performance, and exploits the offensive capabilities of directed energy systems, developing modeling and simulation tools to unite bioeffects and human performance models from across the Department of the Air Force (DAF) in support of Digital Transformation initiatives. In addition, this Project develops, demonstrates, and prepares for transition technologies that provide Airman-integrated capabilities to sustain, enhance, and augment airmen physical and cognitive performance under challenging and adverse operational and training mission environments; maturing technologies to provide commanders real time status monitoring and assessment of individual's mission ready status and intervention protocols to accelerate restoral to combat readiness. Further, this Project develops, demonstrates, and transitions advanced training, simulation, mission rehearsal, and other performance-aiding methods and technologies to enhance warfighter readiness focusing on integrated high-fidelity weapon systems training technologies; tailored immersive simulation environments for airmen at the tactical and operational levels; and incorporation of performance assessment and feedback tools. Finally, this Project develops, demonstrates, and readies the transition of technologies to revolutionize the way airmen optimize multi-Unmanned Aerial Vehicle, Battle Management Command and Control, Command, Control, Communications and Battle Management, and intel analysis capabilities of DAF systems, including autonomous machines, and adaptive teams of Airmen and machines.
Project 635323 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 5.9 |
| FY2026 | Enacted | 4.9 |
| FY2027 | Request | 20.3 |
| FY2028 | Outyear | 17.8 |
| FY2029 | Outyear | 21.4 |
| FY2030 | Outyear | 21.8 |
| FY2031 | Outyear | 22.3 |
4 accomplishments / planned programs
The R-2A exhibit — the only level of the budget that describes work that has not happened yet. Activities carry the prior, current and budget year only, no five-year plan. Coverage is partial across the corpus, so count activities, never total them.
FY2027 planned work -Continue developing Advanced Command and Control software for distributed operations by advancing the long-range kill web-Enabling Technologies and developing the associated distributed Planning and Command and Control tools. -Continue developing Collaborative interfaces that leverage Artificial Intelligence, conducting a critical examination of the introduced Artificial Intelligence synthetic agents and expanding mission Planning tools for Autonomous assets. -Continue developing Artificial Intelligence-aided full-mission planning technology for Airmen and Guardians by conducting evaluations of the integrated mission planning, debrief, and Human-Machine Interfaces for contingency…
FY2026 to FY2027 change FY 2027 funding increased compared to FY 2026 by $8.937 million due to the transfer of the Airman Machine Interfaces effort and associated funding within this Program Element from Project 635325/Warfighter Interfaces to Project 635323/ Directed Energy Bioeffects Parameters. However, the overall funding for the Airman Machine Interfaces effort increased from FY 2026 by $4.538 million due to increased emphasis on accelerating human-machine teaming technology maturation and advancing next generation command and control interfaces.
FY2026 plans — current year In the FY 2025 and FY 2026, the Airman Machines Interfaces effort and funding were reported in Program Element 0603456F/ Human Effectiveness Advanced Technology Development Project 635327 / Warfighter Interfaces. FY 2025 funding was $1.290 million, and FY 2026 funding is $4.399 million.
FY2027 planned work -Continue providing hazard analysis for directed energy and novel weapon systems, maturing modeling capabilities to improve hazard assessments and conducting performance analysis to support the required directed energy weapon review and approval process for novel systems. -Continue providing human-based design requirements addressing operational and mission performance of counter-directed energy technologies, delivering expert analysis for the Nuclear Flash Blindness Protection and Aircrew Laser Eye Protection Block 4 programs. -Continue demonstrating and integrating high peak power radio frequency and laser human effects assessment models to address real world concerns, providing subject…
FY2026 to FY2027 change FY 2027 funding Increased compared to FY 2026 by 4.910 million due to the transfer of the Directed Energy Bioeffects effort and associated funding within this Program Element from Project 635323 / Directed Energy Bioeffects Parameters to Project 635323/ Human Effectiveness Technology Demonstration. However, the overall funding for the Directed Energy Bioeffects effort increased from FY 2026 by 0.010 million due to minor programmatic adjustments to the DAF Science and Technology portfolio. FY2025 funding was 5.858 million and FY2026 Funding is 4.900 million.
FY2026 plans — current year -Continue to provide hazard analysis for directed energy and novel weapon systems under development, demonstrating new validated capabilities for personnel hazard assessments by conducting reflectance measurements and analysis to support the required directed energy weapon review and approval process. -Continue to provide human-based design requirements optimizing operational and mission performance for counter-directed energy weapon technologies by providing subject matter expertise and modeling & simulation analysis. -Continue to demonstrate and integrate high peak power radio frequency and laser human effects assessment models and tools to address real world concerns by providing…
FY2027 planned work -Continue integrating training management, data tracking tools, and interfaces into the Synthetic training Infrastructure by improving and upgrading the specific exercise tracking and debrief tools at the Distributed Training Center and Distributed Mission Operations Center. -Continue field evaluations of the proficiency-based training infrastructure by updating hardware and software at the Distributed Training Center and Distributed Mission Operations Center based on lessons learned from effectiveness evaluations. -Continue systematic evaluations of live-virtual-constructive technology on operational readiness by expanding the deployment of simulator fidelity models to more Distributed…
FY2026 to FY2027 change FY 2027 funding increased compared to FY 2026 by $4.201 million due to the transfer of the Readiness Technology Development effort and associated funding within this Program Element from Project 635325 / Mission Effective Parameters to Project 635323 / Human Effectiveness Technology Demonstration. However, the overall funding for the Readiness Technology Development effort decreased from FY 2026 by $1.882 million due to reprioritization of the mission sets evaluated. This reduction reflects programmatic adjustments to the DAF Science and Technology portfolio for strategic realignment to optimize core research areas and improve resource efficiency.
FY2026 plans — current year In the FY 2025 and FY 2026, the Readiness Technology Demonstration effort and funding were reported in Program Element 0603456F/ Human Effectiveness Advanced Technology Development Project 635325 / Mission Effective Performance. FY 2025 funding was $3.638 million, and FY 2026 funding is $6.083 million.
FY2027 planned work -Continue development of physio-cognitive state prototype system by executing high-altitude chamber and centrifuge testing to validate AI-enabled state assessment for aircrew. -Complete system development of the Fatigue Optimized Cognition Under Stress (FOCUS) fatigue Management system, delivering final data analysis, lessons learned, and identifying future transition opportunities with AFRL and other customers. -Complete the transcutaneous vagal nerve stimulation (tVNS) fatigue countermeasure demonstration, delivering final test results, lessons learned, and user documentation to prepare for transition to DoW users.
FY2026 to FY2027 change FY 2027 funding increased compared to FY 2026 by $2.290 million due to the transfer of the Biotechnology for Performance Research and Demonstration effort and associated funding within this Program Element from Project 635324/Biosciences Performance Demonstration to Project 635323/ Human Effectiveness Technology Demonstration. However, the overall funding for the Biotechnology for Performance Research and Demonstration effort decreased from FY 2026 by $1.877 million due to completion of three major activities: integration of eye-tracking fatigue assessment algorithm, development of secure, cloud-based data system for in-flight physiological data, and development of Airmen/Aircrew fatigue…
FY2026 plans — current year In FY 2025 and FY 2026, the Biotechnology for Performance Research and Demonstration effort and funding were reported in Program Element 0603456F/ Human Effectiveness Advanced Technology Development Project 635324 / Biosciences Performance Demonstration. FY 2025 funding was $2.763 million, and FY 2026 funding is $4.167 million.